Pulse Biosciences rights offering oversubscribed, raises $60M; Duggan to hold ~72%

PULSE BIOSCIENCES, INC.

Offering oversubscribed at 138%, receiving over $83M in subscriptions vs $60M limit.
Expected gross proceeds of $60M from sale of ~6M units at $10/unit.
Executive Chairman Robert Duggan subscribed for ~5M units, boosting his ownership to ~72%.
Warrants could generate up to $66M additional proceeds if exercised; exercise price $11/share.
Units consist of one share and two warrants; warrants expire in five years with redemption conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.